As with any antihypertensive agents, excessive blood pressure decrease in patients with ischaemic cardiovascular and cerebrovascular disease could result in a myocardial infarction or stroke.
Njenganoma imuphi umenzeli we-antihypertgency, ukwehla ngokweqile kwengcindezi yegazi ezigulini ezine-ischemic cardiopathy noma isifo se-ischemic senhliziyo kungaholela ekuqhekekeni kwe-myocardial noma stroke.